Medical Disclaimer: This data is for informational purposes only. Success rates are influenced by patient age, diagnosis, and treatment type. Do not use this data alone to choose a fertility clinic. Consult a board-certified reproductive endocrinologist.

CDC NASS 2022 818 ART cycles Texas

Aspire Fertility-Dallas

Aspire Fertility-Dallas reported a 32.0% overall live-birth rate across 818 ART cycles in Addison, Texas (CDC NASS 2022).

Addison, Texas · ZIP 75001 · Last reported: 2022

Aspire Fertility-Dallas, located in Addison, Texas, reports an overall IVF success rate of 32.0% across 818 reported cycles (CDC NASS 2022). Patients under 35 see a success rate of 42.1%. Age-group breakdowns and historical trends are below.

Total Cycles

818

Reported 2022

Overall Success Rate

32.0%

Live births per cycle

-3.4pp vs TX avg

Rate Under 35

42.1%

Peak fertility cohort

Single Embryo Transfer

38.9%

ASRM-aligned safety metric

SET adherence vs national reference

Single-embryo-transfer rate is an ASRM-aligned safety metric — higher SET reduces multi-pregnancy and OHSS risk.

Aspire Fertility-Dallas SET rate 38.9%
78% national reference

Share of transfers using one embryo only

Success Rates by Age Group

Using own eggs (fresh + frozen cycles). CDC reports patients over 40 as a single group.

Under 35 42.1%
35–37 29.7%
38–40 30.9%
Over 40 7.1%

Success rate = live births per ART cycle started. Source: CDC NASS 2022.

Cycle Breakdown

Total Cycles
818
Fresh Cycles
25
Frozen Cycles
793
Years Reporting
3
Single Embryo Transfer %
38.9%

Services Available

  • Donor Egg Available
  • Gestational Carrier
Texas State Average
35.4%
View all 47 clinics in Texas →

What the CDC NASS Data Shows for Aspire Fertility-Dallas

Aspire Fertility-Dallas reported cycle outcomes to the CDC National ART Surveillance System for the 2022 reporting year, with 3 years of cumulative reporting history. The clinic performed 818 total ART cycles, split between 25 fresh and 793 frozen embryo transfer cycles. The overall success rate — live births per cycle started — was 32.0%. That is 3.4 percentage points below the Texas state average of 35.4%, which may reflect a more complex patient case mix rather than quality of care.

Age remains the dominant variable in IVF outcomes. At Aspire Fertility-Dallas, patients under 35 saw a 42.1% success rate, compared with 29.7% for ages 35–37 and 30.9% for ages 38–40. The over-40 cohort reported 7.1%. Single embryo transfer (SET) was used in 38.9% of cycles, a metric ASRM associates with lower multi-pregnancy rates.

Service availability also affects which clinics fit which patients. Aspire Fertility-Dallas does report donor egg services and does offer gestational carrier (surrogate) cycles. These services matter for patients with diminished ovarian reserve, same-sex couples, or medical conditions that preclude carrying a pregnancy. Every figure above is a public federal disclosure, not editorial commentary — PlainFertility is not affiliated with Aspire Fertility-Dallas or the CDC, and these statistics are not a substitute for an evaluation by a board-certified reproductive endocrinologist who can assess your individual diagnosis, history, and treatment options.

Read these figures as a starting point, not a verdict. The CDC reports live births per intended egg retrieval, so the percentages already account for cycles that never reached embryo transfer — a more conservative measure than the per-transfer pregnancy rates clinics sometimes advertise. Group results describe what happened for past patients; they cannot predict an individual outcome, which depends on diagnosis, ovarian reserve, sperm quality, embryo genetics, and the protocol a physician recommends. A single reporting year can swing for lower-volume clinics, so cumulative multi-year results and a candid consultation carry more weight than any one published number.

Historical Success Rates

Year Total Cycles Overall Under 35 35–37 38–40 Over 40
2022 818 32.0% 42.1% 29.7% 30.9% 7.1%
2021 630 36.2% 50.4% 31.7% 17.9% 11.1%
2020 461 N/A N/A N/A N/A N/A

Frequently Asked Questions

Aspire Fertility-Dallas's IVF success rate

Aspire Fertility-Dallas reports an overall IVF success rate of 32.0% across 818 reported cycles. Rates by age group vary — patients under 35 generally see higher success rates.

How should I interpret these success rates?

IVF success rates depend on patient age, diagnosis, embryo type, and treatment protocol. A clinic with a lower success rate may treat more complex cases. Always consult a board-certified reproductive endocrinologist who can evaluate your individual situation.

Where does this data come from?

All data is sourced from the CDC's National ART Surveillance System (NASS), which requires all ART clinics in the US to report their cycle outcomes annually under the Fertility Clinic Success Rate and Certification Act of 1992.

What is the difference between fresh and frozen IVF cycles?

Fresh cycles use embryos that have not been frozen — eggs are retrieved, fertilized, and transferred within the same treatment cycle. Frozen cycles use previously cryopreserved embryos. Aspire Fertility-Dallas reported 25 fresh cycles and 793 frozen cycles. Many clinics now favor frozen embryo transfers (FET) due to improved vitrification technology and comparable or higher success rates.

What does single embryo transfer (SET) percentage mean?

Single embryo transfer percentage indicates how often a clinic transfers just one embryo per cycle rather than multiple embryos. A higher SET rate generally reflects adherence to current ASRM guidelines aimed at reducing multiple pregnancies. Aspire Fertility-Dallas reports a SET rate of 38.9%. Higher SET rates typically mean fewer twins and triplets, which reduces pregnancy complications.

Does this clinic offer donor egg or gestational carrier services?

Aspire Fertility-Dallas does offer donor egg services and does offer gestational carrier (surrogate) services per the latest CDC NASS report. Contact the clinic directly to confirm current service availability and discuss whether these options are appropriate for your treatment plan.

Data source: CDC National ART Surveillance System (NASS). PlainFertility is not affiliated with the CDC or this clinic.

Related

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainFertility Editorial